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How Do Viruses Enter Cells? Meeting Review
The HIV Coreceptors Teach Us
a Lesson of Complexity
be computationally perturbed to fit EM-derived density
maps of unstable transitional states that may be inac-
cessible to crystallography.
The latter approach was applied to investigate the
transition undergone by poliovirus (z30 nm diameter,
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Miller Drive 160S particle) after interacting with host cell but prior
to release of the RNA (135S particle, 33 nm diameter,Frederick, Maryland 21702-1201
ªA particleº) (J. Hogle, Harvard Medical School, Boston).
The combined use of crystallography and cryo-EM was
also applied to probe receptor-capsid interactions ofThe discovery that several chemokine receptors can
rhinovirus (with soluble ICAM-1) and parvovirus (withserve as HIV-1 coreceptors (Alkhatib et al., 1996; Choe
globoside). In both cases, the receptor and its bindinget al., 1996; Deng et al., 1996; Doranz et al., 1996; Dragic
site were visualized: in neither case is the virion appreci-et al., 1996; Feng et al., 1996) and the engineering of a
ably perturbed by this interaction. The structure of therecombinant virus that specifically targets cells express-
native bovine papillomavirus was determined by cryo-ing fusogenic HIV-1 envelope glycoprotein (Env) (Schnell
EM and 3-D image reconstruction at 0.9 nm (F. Booy,et al., 1997) highlighted the importance of an old ques-
NIAMSD, NIH, Bethesda) (Trus et al., 1997). The hightion: how do viruses enter cells? The identification and
resolution allowed identification of intercapsomere pro-characterization of the HIV coreceptors not only re-
tein connections (z1 nm in diameter), which were notsolved a long-standing puzzle and elucidated a number
seen at 1.1 nm resolution. Whether these connectionsof phenomena that had been observed in the past de-
are important for entry remains to be determined.cade (reviewed in a recent book [Dimitrov and Broder,
1997]) but it also demonstrated the complexity of the
multifactorial and multistage process of virus entry. Three-Dimensional Structure of Viral
What are the molecular mechanisms determining the Envelope Proteins
complexity of virus entry? How can knowledge of virus The initial stages of attachment and induction of confor-
entry help in prevention and treatment of diseases? Pos- mational changes for both nonenvelopedand enveloped
sible answers to these fundamental and many other viruses could be quite similar. However, for only a few
specific questions were discussed at a recent meeting envelope proteins has the 3-D structure been solved to
on The Cell Biology of Viral Entry (September 21±24, allow for extensive comparison. For morethan a decade,
Frederick, Maryland) organized by R. Blumenthal (Na- the only solved 3-D structure of fusion mediating enve-
tional Cancer Institute, USA) and sponsored by the Na- lope protein was that of the influenza hemagglutinin (HA)
tional Cancer Institute and the Office of AIDS Research, (Wilson et al., 1981). In an explosion of recent develop-
NIH. A major goal of the meeting was to bring together ments, several new 3-D structures have been solved.
leading scientists from around the world to discuss dif- Among these were fragments of: the major envelope
ferent aspects of the mechanisms of virus entry, includ- glycoprotein (E) of the tick-borne encephalitis (TBE) vi-
ing three-dimensional (3-D) structures of viruses, virus rus (Rey et al., 1995), the low-pH form of the HA trans-
receptors, and fusion kinetics, as well as the develop- membrane protein (Bullough et al., 1994), the ectodo-
ment of entry inhibitors and delivery systems targeting main of Moloney murine leukemia virus (MoMuLV) (Fass
specific cell types. et al., 1996), and the HIV-1 gp41 (Weissenhorn et al.,
1997; Chan et al., 1997). P. Kim (Whitehead Institute
for Biomedical Research, MIT, Cambridge) reported theThree-Dimensional Structure
of Nonenveloped Viruses latest in this series of achievementsÐthe solution of the
3-D structure of a fragment of the Friend MuLV EnvThe mechanism of virus entry is critically dependent
on the 3-D structure of the infecting virion. Many DNA containing the receptor-binding site. The core of the
receptor-binding domain is an antiparallel beta sand-viruses and some RNA virusesÐboth plus-stranded and
double-strandedÐdo not have membranous envelopes wich, with two interstrand loops forming a helical subdo-
main atop the sandwich. The residues in the helicalbut interact with host cells via their capsid proteins. For
smaller viruses, the major (or only) capsid protein serves region, but not in the beta sandwich, are highly variable
among mammalian C-type retroviruses with distinct tro-this purpose, but larger and more complex viruses (e.g.,
adenovirus, reovirus, DNA phages) have minor capsid pisms, indicating that the helical subdomain determines
the receptor specificity of the virus (Fass et al., 1997).proteins, called spikes or fibers, at particular capsid
sites (e.g., vertices) that recognize host receptors. A. It would be interesting to compare the details of this
structure with the more extensively studied high-affinitySteven (NIAMS-NIH, Bethesda) discussed how X-ray
crystallography and cryo±electron microscopy (cryo- receptor-binding sites of nonenveloped viruses, espe-
cially human rhinoviruses (M. Rossmann,Purdue Univer-EM) complement each other as applied to viruses.
Molecular details of large virions can be obtained by sity, West Lafayette). At this pace of research, we may
soon be able to look at the HIV-1 gp120 structure.combining high-resolution X-ray structures of protein
components with lower-resolution EM structures of The known structures of nonenveloped virus coat and
envelope proteins suggest that helical structures arewhole virions; likewise, X-ray structures of virions may
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involved in the binding specificity. Helices, but in coiled tropic strains of HIV-1 and SIV (Alkhatib et al., 1997; Liao
et al., 1997). Sodroski (Harvard Medical School, Boston)coils, are also involved in formation of oligomers and
may serve as fusion intermediates. D. Wiley (Harvard described two orphan seven-transmembrane segment
receptors, GPR1 and GPR15, that serve as coreceptorsUniversity, Cambridge) discussed the evidence that the
coiled coils of the low-pH form of HA are fusogenic for SIV and are expressed in human alveolar macro-
phages (Farzan et al., 1997b). The more efficient ofintermediate structures. Experiments with HA2 polypep-
tide residues 38±175 expressed in Escherichia coli sug- these, GPR15, is also expressed in human CD41 T lym-
phocytes and activated rhesus macaque peripheralgested that the structure of the low-pH-induced fold of
viral HA2 (TBHA2) observed crystallographically is the blood mononuclear cells. GPR15 and STRL33 are the
same as BOB and Bonzo, respectively, recently isolatedlowest-energy-state fold of the HA2 polypeptide. This
structure folds in vivo into a trimer. These results indi- by D. Littman and his colleagues (Deng et al., 1997).
V28 and CCR8 were recently shown to serve as HIVcate that the HA2 conformation in viral HA is metastable
at neutral pH and suggest that removal of the receptor- coreceptors (R. Doms, E. Berger) (see also Reeves et
al., 1997). With the identification of US28, encoded bybinding chain (HA1) is sufficient to allow HA2 to adopt
the stable state. Furthermore, they provide direct evi- human cytomegalovirus (Pleskoff et al., 1997), the num-
ber of coreceptors used by HIV and/or SIV is now tendence that low pH is not required to form the membrane-
fusion conformation but acts to make this state kinet- (CCR5, CXCR4, CCR3, CCR2b, STRL33, GPR15, GPR1,
V28, CCR8, and US28). This number does not includeically accessible in viral HA.
The striking similarity between the low pH (fusion) nonhuman analogs and is likely to grow. How many
molecules can serve as immunodeficiency virus core-structure of the influenza HA and the fusogenic struc-
tures of the transmembrane proteins from MuLV and ceptors is presently unknown. An interesting possibility
is that some HIV-1 entry cofactors may not be proteinsHIV-1 may indicate that not only influenza but also some
retroviruses could use a ªspring-loadedº mechanism at all butglycolipids (A. Puri;R. Blumenthal, NCI-FCRDC,
Frederick). A neutral glycolipid,possibly with three sugar(Carr and Kim, 1993; Bullough et al., 1994) to relocate
the hydrophobic fusion peptides (P. Kim). Especially groups in the polar head group can serve as an alterna-
tive and/or additional cofactor in CD4-dependent HIV-1interesting is the possibility for design of small molecule
inhibitors of HIV-1 entry based on the 3-D structure of fusion. This adds a new dimension to the ability of HIV-1
to use a variety of molecules as coreceptors.the HIV-1 fusion core and the inhibitory properties of
peptides derived from this core. The 3-D dimensional structure of the HIV-1 corecep-
tors is presently unknown. A theoretical 3-D model ofThe oligomeric structure of the HIV-1 Env was dis-
cussed extensively.The majorityof thediscussants sup- CXCR4 and CCR5 was developed by S. Durell (NCI, NIH,
Bethesda), based on the physically determined struc-ported the view that the Env is a trimer. D. Wiley pointed
out that a misinterpretation of some previous experi- tures of both bacteriorhodopsin and rhodopsin, as well
as analysis of the amino acid sequences of relatedments contributed to considerations of other Env oligo-
meric forms. G-protein coupled receptors. The model highlighted dif-
ferences in the electrostatic potentials of the extracellu-
lar portions of the molecules, which may be important
Virus Receptors and Coreceptors for virus tropism.
Many viruses have evolved to utilize cell surface mole- It appears that in the evolution of HIV, ªcoreceptorsº
cules for gaining access into the cell interior. The discov- may have initially served as receptors and the use of
ery of specific bacteriophage attachment to Shigella by CD4 is a more recent adaptation, as was originally sug-
d'Herelle in the beginning of this century was followed gested by R. Weiss (reviewed in (Dimitrov and Broder,
by extensive studies of the bacteriophages (D. Dimitrov, 1997)). The participants of the meeting supported that
NCI-FCRDC, Frederick). These studies demonstrated notion, particularly based on the observations that
that a variety of carbohydrates, lipopolysaccharides, strains of SIV can infect CD4-negative cells by using
and proteins (i.e., virtually every structure exposed at CCR5 as a receptor molecule (R. Doms, University of
the bacterial surface) can serve as a phage receptor. Pennsylvania; J. Sodroski), and that some strains of
As found with bacteria, any structure exposed at the HIV-2 enter CD4-negative cells (Clapham et al., 1992)
cell surface could serve as an animal virus receptor. by using CXCR4 (Endres et al., 1996) as observed by
Although the 3-D structure of only a few virus receptors Clapham, Hoxie and colleagues.
is yet known, their chemical composition precludes pos- Whether other viruses can use so many coreceptors
sible relationships between receptor and virus attach- and other entry cofactors still remains unknown. How-
ment protein (VAP) structures. ever, entry cofactors have been identified for some vi-
Since the discovery that four chemokine receptors ruses, e.g., adenoviruses as noted by A. Helenius (Yale
can also serve as HIV-1 coreceptors, five new human University, New Haven) during the discussion. In some
molecules have been identified as entry cofactorsÐ cases, the existence of entry cofactors has not been
GPR15, STRL33, GPR1, V28, and CCR8. STRL33 is a confirmed by further experimentation. For example,
novel human seven-transmembrane domain orphan re- there is no evidence for poliovirus entry cofactors in
ceptor that is related to chemokine receptors and is spite of some early experiments indicating that CD44
expressed in activated peripheral blood lymphocytes may have such a function (V. Racaniello, Columbia Uni-
(PBLs) and T-cell lines (J. Farber, NIAID, NIH). It func- versity). This reminds us the lessons from the long story
tions as an entry cofactor for Envs from macrophage- of the many HIV-1 candidate entry cofactors (Dimitrov
and Broder, 1997).tropic (M-tropic), T-cell line±tropic (T-tropic), and dual
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Attachment of Viruses to Receptor Molecules CCR5, it has been convincingly demonstrated that the
CCR5 N-terminus plays a critical role for entry ofand Formation of Multimeric Complexes
Viruses can be divided into two groups with respect to M-tropic HIV-1 and SIV (R. Doms) (Doranz et al., 1997;
Edinger et al., 1997). A second functional region whichtheir interactions with receptor molecules: those with
high affinity to their receptors (e.g., rhinovirus, poliovi- is important for entry includes the extracellular loops.
Several individual residues in both functional regions,rus, and HIV) and those with low affinity (e.g., polyoma,
SV40, and influenza). As a rule, the high affinity interac- Asp-11, Lys-197, and Asp-276, contributed significantly
to the coreceptor function. The T-tropic SIV requiredtions serve a dual function; in addition to attachment
they also induce conformational changes needed for the the second extracellular loop. This loop was also critical
for entry of T-tropic and dual tropic HIV-1 and HIV-2subsequent stages of entry. The low affinity interactions
require a low pH trigger for entry. In a striking example strains, but the first extracellular loop was also required
for some strains (Lu et al., 1997). In agreement withof how much we know about structural details of virus-
receptor interactions M. Rossman (Purdue University, these results T. Dragic found that the CCR5 amino-
terminus is the major site of interaction with gp120,West Lafayette) described the predicted 3-D structure
of the ICAM-1 D1D2 fragment fitted into the human rhi- particularly the negatively charged aspartic acid resi-
dues at positions 2 and 11, and a glutamic acid residuenovirus canyon. Similar considerations apply also to
parvovirusand its receptor. In bothcases, theCD4 mole- at position 18. Since the CC-chemokine-mediated inhi-
bition of HIV-1 entry is dependent mostly on the CCR5cule can be fitted into the nonenveloped virus canyon.
This indicates similarities between the 3-D structure of second extracellular loop, it appears that the gp120 and
CC-chemokine binding sites on CCR5 are only partiallythe HIV Env CD4 binding site and the receptor binding
site of these nonenveloped capsid proteins. Whether overlapping. J. Sodroski also noted the importance of
the CCR5 N-terminus of CCR5 for interactions withthis similarity extends todetails in molecular interactions
may soon be evaluated when the 3-D structure of gp120 M-tropic HIV strains and SIV. A motif rich in tyrosine
residues was found, that is critical for the interactionsbecomes available. Similar structures may be responsi-
ble for the attachment of poliovirus to its receptor (V. with the immunodefficiency viruses, and was used for
identification of new coreceptors (GPR1 and GPR15)Racaniello, Columbia University, New York; J. Hogle).
The identification of the major HIV-1 coreceptors and (Farzan et al.,1997a). The coreceptor surface expression
levels, particularly CCR5, affect significantly entry effi-the recent solution of the crystal structure of the entire
extracellular portion of CD4 (Wu et al., 1997) provided ciency and, therefore, must be accurately quantitated
in all cases when comparing effects of mutations (J.new opportunities to study the high affinity virus-recep-
tor interactions in greater detail. The oligomeric HIV Env Sodroski).
The HIV-1 Env regions interacting with the corecep-could ªcrosslinkº the dimeric CD4 potentially leading
to formation of large multimeric complexes (C. Broder, tors may involve conformational epitopes related to the
V3 loop of gp120 (J. Sodroski) (Trkola et al., 1996; WuUSUHS, Bethesda). While the oligomeric state of the
HIV-1 coreceptors is currently unknown, it has been et al., 1996). This result may explain numerous data
relating the V3 loop to virus tropism (reviewed in (Dimi-demonstrated that they associate with the gp120-CD4
complex and possibly with CD4 in the absence of gp120 trov and Broder, 1997)) and is in aggreement with a
conceptual model of the Env-CD4-coreceptor interac-(H. Golding, FDA, Bethesda; Q. Sattentau, Centre d'Im-
munologie de Marseille-Luminy, Marseille) (Ugolini et al., tions suggested earlier (Dimitrov, 1996).
Most of our knowledge on HIV-1 coreceptor interac-1997; Trkola et al., 1996; Wu et al., 1996; Lapham et al.,
1996). Although the affinities of membrane-associated tions has been derived either by experiments with solu-
ble components of the entry machinery or measure-coreceptor-CD4 interactions are presently unknown, an
interesting concept is the possibility that competition ments of end results of those interactions, such as
fusion, entry, or infection. By using a novel virion bindingfor use of CD4 leads to changes in tropism. C. Broder
briefly described his experiments with macrophages assay, Q. Sattentau and his colleagues directly mea-
sured the interactions between membrane-associatedwhere overexpression of CXCR4 seems to allow entry
of T-cell line tropic (T-tropic) viruses. One possible inter- HIV-1 Env, CD4, and coreceptors. They found that HIV-1
may require both CD4 and coreceptor molecules forpretation of these results is that at low CD4 concentra-
tion CCR5 outcompetes CXCR4 for CD4 (Q. Sattentau) efficient binding to cells.
Plasma membranes contain thousands of proteins,(Broder and Dimitrov, 1996). At high CXCR4 concentra-
tions, CXCR4 could associate with CD4 allowing entry many of them being potentially capable of interacting
with virus components and/or receptor molecules, es-of T-tropic viruses.
The delineation of the critical regions involved in the pecially at elevated surface concentrations. The human
multidrug transporter (P-glycoprotein) is a large integralinteractions within the HIV-1 Env-CD4-coreceptor com-
plex are presently under intensive investigation (E. Ber- membrane protein that extrudes hydrophobic drugs and
peptides from the plasma membrane. Interestingly, itger, NIAID, NIH, Bethesda; R. Doms, University of Penn-
sylvania; T. Dragic, Aaron Diamond AIDS Research also interferes with HIV-1 infection at the level of entry
(M. Gottesman; C. Lee, NIH, Bethesda). A possible ex-Center, New York; J. Sodroski, Harvard Medical School,
Boston; P. Clapham, Institute of Cancer Research, Lon- planation for its inhibitory effect is the interaction with
hydrophobic portions of the HIV Env, particularly thedon). The exchange of different portions between CCR3
and CCR1 indicates that the N-terminus does not affect fusion peptide. However, it was found that another large
integral membrane protein (CFTR), which serves as antheentry of the dual tropic virus 89.6 (E. Berger). Byusing
a large number of mutants, chimeras, and homologs of ionic channel, also affects fusion. Therefore another
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possible inhibitory mechanism may involve interactions of the HIV coreceptors raised the question of whether
the fusion mechanism involves further conformationalwith receptor and coreceptor molecules (D. Dimitrov).
Although the mechanisms of the inhibitory effects of changes mediated by the coreceptors. R. Blumenthal
reported on a novel method for the detection of confor-large integral membrane proteins are currently un-
known, their very existence again underlines the com- mational changes in HIV Env based on the fluorescent
dye bis-ANS, which fluoresces after binding to hy-plexity of virus entry through the plasma membrane.
drophobic regions. By using this method, he and his
colleagues found that significant conformational changes
Conformational Changes Induced occur only in the presence of coreceptor molecules.
by Receptors and Low pH Notably, the type of coreceptor was important for the
Viruses are subjected to two conflicting requirements: interaction with either M- or T-tropic virus: expression
stability, the requirement to survive in the environment, of CXCR4 and CD4 at thecell surface induced conforma-
and destabilization, the need to enter the cell. Therefore, tional changes in T-tropic HIV Env while CCR5 and CD4
a trigger must exist to destabilize them at the right time led to conformational changes in M-tropic isolates.
and place. Currently, a leading hypothesis is that the It appears that an increase in hydrophobicity following
virus entry proteins are in a metastable state. They re- receptor-induced conformational changes is also an es-
quire a trigger (receptor or low pH) to provide the needed sential requirement for entry of other retroviruses. J.
activation energy to overcome the energy barrier and White (University of Virginia, Charlottesville) presented
move to a more stable energetically favorable state. In evidence that the binding of soluble forms of the recep-
line with this hypothesis, J. Hogle proposed that the tor (TVA) to soluble oligomeric avian leukosis and sar-
poliovirus receptor serves as a catalyst that releases the coma virus (ALVS) envelope glycoprotein (Env-A) ren-
mature virion from a metastable state. Thus, it promotes ders the Env-A hydrophobicas demonstrated bybinding
conformational changes in which VP4 and the amino to liposomes composed of phosphatidylcholine and
terminus of the capsid protein VP1 are externalized, cholesterol. Unexpectedly, the receptor dissociated
possibly in a way similar to the spring-loaded mecha- from the Env-A after inducing the conformational
nism suggested for influenza (Carr and Kim, 1993; Bul- changes. A mutant receptor that binds Env-A, but does
lough et al., 1994), leading to association with mem- not support ALSV infection, did not induce significant
branes. Notably, the same (or similar) conformational liposome binding indicating that binding and induction
changes can be induced by elevation of temperature to of conformational changes are separable functions of
458C±508C or by hypotonic medium containing calcium. the receptor molecule.
Therefore in this, and probably other cases too, the Conformational changes can also be induced by low
receptor functions to lower the activation barrier for pH in a large number of nonenveloped and enveloped
the conformational changes at 378C. It appears that the viruses. Perhaps the most studied virus in this aspect
conformational changes in the poliovirus-receptor com- is influenza. It appears that cleavage of the influenza
plex occur in several stages (V. Racaniello). Cold- HA precursor leads to formation of a metastable state
adapted mutants were isolated that replicate efficiently, of HA2 and the low pH triggers the transition to the more
but formation of 135S particles, considered as possible energetically stable state by a series of conformational
entry intermediates, was not observed. The question of changes (D. Wiley). However, the neutral pH form of
whether the 135S particles are entry intermediates intact HA is most stable as found by differential scanning
needs further investigation. Human rhinoviruses and calorimetry (R. Blumenthal). With the recent achieve-
parvovirus are also destabilized by interactions with ments in elucidating the 3-D structure of possible fusion
their receptors (M. Rossmann). intermediates, the most striking finding is the similarity
That the primary HIV receptor CD4 induces conforma- in the structures involved in the conformational changes
tional changes in the Env-CD4 complex has been known induced by receptors (MuLV) and triggered by low pH
for many years (reviewed in Dimitrov and Broder, 1997). (influenza) (P. Kim, MIT, Cambridge). The conformational
Another demonstration of the CD4 ability to ªprimeº the changes leading to an increase in hydrophobicity, as
virus for the subsequent stages of entry by inducing detected by the fluorescent dye bis-ANS in the influenza
conformational changes was thedemonstration that sol- HA after exposure to low pH, may also have some simi-
uble CD4 (sCD4) can promote HIV-1 fusion with CD4- larities with those induced in the HIV-1 Env by CD4
negative cells (E. Berger). Although it has been pre- although the kinetics are different (T. Korte; R. Blumen-
viously reported that sCD4 can induce HIV-2 fusion with thal NCI-FCRDC, Frederick). While coiled coils are cer-
CD4-negative cells (Clapham et al., 1992), this is the first tainly important as fusion intermediates for several vi-
report that a similar phenomenon exists for HIV-1. E. ruses, it appears that in some (or many ?) cases other
Berger pointed out that the clue for the success (and the structures could play a role. It would be interesting to
failures of many previous efforts since 1990, including determine whether coiled coils are also involved in the
those of several participants at the meeting) was the structure of the fusion intermediates for the TBE virusÐ
ability to express a coreceptor molecule at high levels the structure of its major glycoprotein implies close
by using a vaccinia recombinant. Interestingly, a mono- proximity to the target membrane (Rey et al., 1995) and
clonal antibody (MAb), CG10, which is strictly specific no requirement for translocation of the fusion peptide.
for the CD4-gp120 complex, enhanced HIV-1 Env-medi- In addition, no coiled coils are predicted for certain vi-
ated fusion and infection, possibly due to an increased ruses, for example, for the VSV G protein.
exposure of intermediate structures interacting with With the advances in cryo-EM and image reconstitu-
tion, we are now able to see a high time resolution (50coreceptor molecules (H. Golding). The identification
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ms) dissection of stages in the dynamics of pH-induced that exogenous lipids, such as lysophosphatidylcholine,
can also interact directly with fusion peptides, whichconformational changes (S. Fuller, European Molecular
Biology Laboratory, Heidelberg). It appears that a meta- may inhibit the fusion reaction by a mechanism indepen-
dent of interference with fusion intermediates. However,stable trimer of the Semliki Forest Virus (SFV) E1 occurs
early in the fusion process and that lateral interactions lipid binding to the fusion peptide of HA is known to be
fairly nonspecific and oleic acid promotes rather thanbetween spikes in the TBE virus are important for the
formation of an active fusion particle. The SFV E1 homo- inhibits fusion (J. Zimmerberg). In addition, the mem-
brane concentrations of lysolipid inhibiting HA-medi-trimer formation occurs after the binding step follow-
ing the E2/E1 heterodimer dissociation at low pH (J. ated fusion are very similar to those inhibiting fusion of
purely lipid bilayers. These and other data argue againstWilschut, University of Groningen, Groningen). The for-
mation of the trimer may be influenced by the target this possibility.
Formation of multimeric fusion complexes may alsomembrane lipids, especially by cholesterol and sphin-
golipids. F. Heinz (University of Vienna, Austria) elabo- play a role in the HIV-1 Env-mediated fusion. An indica-
tion for the existence of such complexes is that fusion-rated on the structural changes in the oligomeric state
of TBE induced by low pH based on the recently solved deficient mutants of HIV can inhibit fusion when they
are coexpressed with the wild-type Env in the same cellX-ray structure (Rey et al., 1995). Notably, the dimer±
trimer transition induced by low pH is irreversible when as originally observed by E. Freed (NIAID, Bethesda). In
a further development of these studies, it was foundthe major envelope glycoprotein (E) is membrane asso-
ciated but reversible for its soluble form. This transition that the fusion-deficient mutants also inhibit fusion when
they are expressed in the target CD4 cell, indicatingexposes the fusion peptide at the tip of the dimerization
domain leading to fusion. Whether a similar switch from complex interactions of multiple envelope glycoprotein
molecules associated with the two fusing membranesone oligomeric state to another can occur for HIV follow-
ing the interaction with CD4 is presently unknown. Such (P. Hug; R. Blumenthal, NCI-FCRDC, Frederick).
It appears that SFV has the most efficient entry ma-a transition could have resolved one of the long-standing
controversies about the oligomeric structure of the chine knownÐunlike many other viruses, virtually all
virions fuse and fusion is strictly nonleaky (J. Wilschut).HIV-1 Env: tetrameric (dimer of dimers) versus trimeric.
Similar to influenza, fusion is likely to involve a distinct
hemufusion intermediate, since it is inhibited by lyso-
Membrane Destabilization and Fusion phosphatidylcholine and stimulated by free fatty acids.
The conformational changes of the virus proteins result SFV can fuse with liposomes indicating that it does not
in the exposure of their fusion peptides followed by need a protein receptor. However, fusion requires cho-
insertion into target cell membranes as has been ele- lesterol for the low pH-dependent binding of the virus
gantly demonstrated for influenza by J. Brunner (ETH to the target membrane, and also sphingolipids that
Centrum, Zurich) using photolabeling techniques. The catalyze the fusion reaction. Cholesterol is also required
hydrophobic fusion peptides destabilize themembranes for entry of Sindbis virus, and that requirement can be
and, through a series of intermediate steps including manipulated by site-directed mutagenesis of the E1 en-
lipidic structures, lead to the formation and expansion velope glycoprotein (M. Kielian, Albert Einstein College
of the fusion pore (R. Blumenthal) (Blumenthal et al., of Medicine, New York). A detailed kinetic scheme for
1991, 1996). Currently, a hemifusion intermediate is im- different intermediates involved in the HA and VSV fu-
plicated as a lipidic structure required for fusion (J. Zim- sion and a model were proposed by R. Blumenthal (Pak
merberg, NIH, Bethesda, J. Wilschut). Based on data et al., 1997), based on the findings that the conforma-
obtained by using electrophysiological and microfluoro- tional transitions are irreversible for HA and reversible
metric techniques, J. Zimmerberg showed that subse- in the case of the VSV G protein.
quent to the conformational changes and prior to fusion Many HIV-1 gp41 mutants are defective in fusion (E.
pore opening and lipid mixing there are two stages as Hunter, University of Alabama, Birmingham). A trypto-
defined by using exogenous lipids (Chernomordik et phan-rich region that overlaps the neutralizing 2F5 MAb
al., 1997) and low temperature. He proposed that the epitope on gp41 is important for entry and may be posi-
multimeric HA fusion complex (containing about 6 tri- tioned at the membrane surface. In general, the mem-
mers) may restrict the lipid diffusion (a restricted inter- brane proximal domains of primate lentiviruses are criti-
mediate) in order to limit the number of lipid molecules cal for fusion and can also play a role in assembly.
in supposedly nonlamellar fusion intermediates. These The cleavage of the Env locks it in structures that are
lipid molecules of limited number may undergo hemifu- otherwise impossible, and prediction of helical regions
sion induced by HA, which is subsequently transformed may not be valid for the Env before fusion because the
into a restricted fusion pore (Zimmerberg et al., 1994). structures may not be in an energetically stable state.
D. Siegel (Procter and Gamble Co., Cincinnati) ques- How thestructure of distinct regions within virus enve-
tioned the notion for restricted fusion, arguing that lipids lope proteins may affect fusion was discussed by Y. Shai
may diffuse between the HA molecules. Zimmerberg (The Weizmann Institute of Science, Rehovot) based on
proposed that the lipids could be immobilized by the studies with peptides derived from different regions of
formation of lipid/protein microdomains especially at the fusion protein of Sendai virus. Different portions of
high local HA concentrations, leading to immobilization the fusion protein have distinct functions in the assem-
or decrease in their lateral mobility. This idea agrees bly of the fusion protein in solution and membranes, in
with the domain structure of the membrane as noted by membrane destabilization, apposition, and formation of
the fusion pore. For example, SV-150 and SV-473 areD. Dimitrov. T. Stegmann (CNRS, Toulouse) pointed out
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located at similar positions to DP-107 and DP-178 of pore complex, and the DNA is transferred into the nu-
cleus. The hepatitis B virus core binds to the nuclearHIV-1, have similar structures, and coassemble in solu-
tion. However, they have high affinity for membranes, pores only in its phosphorylated form, which suggests
that phosphorylation is important for the nuclear import.dissociate upon their binding, and therefore may assist
in membrane apposition. Notably, the structure of the While the initialstages of binding to the nuclearpore may
have some similarities with attachment of nonenvelopedSendai virus fusion peptide in the membrane is a helical
while that of HIV-1 forms predominantly b sheets al- viruses to cells, the later stages of the transport are
different.though further studies are needed to confirm these re-
sults. The VSV G fusion peptide, unlike other viruses, Vaccinia virus reminds us that the complexity of virus
entry and assembly reaches new dimensions for someis internal and not hydrophobic (H. Ghosh, McMaster
University, Hamilton). However, it is highly conserved large viruses (B. Moss, NIAID, NIH, Bethesda). It is a
very complex virus, has 200 genes and four membranesand contains a motif (G--P---G-----D) similar to that of
the SFV E1 glycoprotein. It was also proposed that the with more than 10 proteins associated with them. This
very large virus has a wide host range but the receptorfusion peptide of influenza promotes cubic phases at
pH 5.0 by changing the kinetics of the lamellar to in- is unknown.The two-membrane intracellularmature viri-
ons are assembled in the cytoplasm and then wrappedverted phase transitions (R. Epand, McMaster Univer-
sity, Hamilton). Some mutations in the fusion peptide of by Golgi-derived membranes to form the four-mem-
brane intracellular enveloped virions, which fuse withwild-type viruses can actually increase the rate of fusion
as demonstrated for the Simian virus 5 (S. Bagai, North- the plasma membrane to release three-membrane ex-
tracellular enveloped virions. Genetic and microscopicwestern University, Evanston).
Although the cytoplasmic tail is not critical for fusion evidence suggested involvement of specific viral pro-
teins in the formation or stability of virus-tipped actin-mediated by the influenza HA (G. Melikyan, Rush Medi-
cal College, Chicago; A. Hermann, Humboldt University, containing microvilli and a role for these structures in
cell-to-cell spread.Berlin) it may play a role in entry of MoMuLV (Januszeski
et al., 1997). A novel membrane-proximal cytoplasmic While the entry and postentry phenomena have been
extensively studied for HIV-1, it appears that an interme-domain (598±616) was identified that facilitates viral fu-
sion (Y. Rozenberg, University of Southern California, diate step, uncoating, has received relatively little atten-
tion. E. Freed (NIAID, NIH, Bethesda) presented resultsLos Angeles). Notably, substitution of the mature cyto-
plasmic tail by a known amphiphilic a helix from melitin suggesting a role of the HIV-1 matrix protein (MA) in
entry, specifically the highly conserved Leu at MA resi-produced fully functional virions, demonstrating the
contribution of the domain's secondary structure in de- due 20, which is likely to affect uncoating.
stabilizing the membranes resulting in enhanced fusion.
Moreover, the analogous cytoplasmic structure is pre-
Virus Entry, Tropism, and Pathogenesisdicted to be conserved among a number of envelopes
While many of theviruses discussed at the meeting havein unrelated viruses. The cytoplasmic tail of HIV-1 also
a wide host range, HIV-1 uses a differentiation antigenmay affect entry and virus assembly (E. Freed, NIAID,
as its primary receptor and has restricted host range.NIH, Bethesda), which is in agreement with earlier obser-
The coreceptor molecules further regulate the types ofvations of the membrane-destabilizing effect of peptides
cells that can be infected. Thus, HIV can serve as aderived from the C terminus of gp41 (Chernomordik et
paradigm to study the interrelations between virus entry,al., 1994).
tropism, and pathogenesis. P. Clapham (Institute ofAn overall conclusion is that, although there is signifi-
Cancer Research, London) described how a set of hu-cant progress in elucidating the molecular details of
man CCR5/mouse CCR5 chimeras worked as core-the membrane fusion process itself, the level of our
ceptors for HIV-1 strains with different tropisms. Dual-knowledge is far behind the recent achievements in elu-
tropic strains (that use CXCR4 as well as CCR5) werecidating the 3-D structure of the virus Env proteins, a
more sus-ceptible to CCR5 sequence changes com-major reason being the difficulty of studying the small
pared to M-tropic strains. Furthermore the same dual-number of molecules participating in the rapid process
tropic strains were exquisitely sensitive to inhibitionof fusion. New approaches are obviously needed.
by RANTES on CCR51CD41 cell lines, while M-tropic
strains needed high RANTES concentrations for inhibi-
tion. These results mean that when HIV adapts to usePostentry EventsÐTransport of Viral Genomes
to Nucleus and Virus Assembly CXCR4 as well as CCR5, then the interaction with CCR5
is compromised, becoming fragile and more sensitiveThe virus life cycle includes attachment, internalization,
penetration, intracellular relocation, and uncoating (A. to alterations in CCR5 sequence as well as to inhibition
by chemokines (Picard et al., 1997). It appears that theHelenius, Yale University, Yale). Herpes simplex virus 1
(HSV-1) and hepatitis B virus, and their capsids, move virus isolates may be better characterized by their usage
of coreceptors rather than by their tropism. This is inthrough the cytosol to the nucleus, interact with the
nuclear pore, and release their genome and proteins into line with an earlier (before identification of the HIV-1
coreceptors) suggestion for redefinition of the virus tro-the nucleus. Both viruses use normal cellular transport
mechanisms to get access to the nucleus. HSV-1 is pism (Chowdhury et al., 1995).
The role of the HIV-1 receptors and coreceptors intransported to the nucleus along microtubules by the
assistance of dynein, a minus-end directed cytosolic pathogenesis continues to be under intensive investi-
gation. A possible mechanism contributing to the HIVmotor; then it binds to fibers at the mouth of the nuclear
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disease progression was suggested by J. Wang (NCI- virus can escape from neutralization. F. Booy compared
the 3-D structure of bovine Papillomavirus obtained byFCRDC, Frederick) who reported inhibition of chemotac-
tic function by gp120 involving CD4-mediated cellular cryo-EM with structures of the virus complexed with two
types of neutralizing MAb to the major capsid protein, L1signaling. Gp120 was also shown to induce internaliza-
tion of the CXCR4 receptor using a functional CXCR4- at 1.3 nm resolution: one antibody (5B6) does not inhibit
GFP fusion protein (G. Pavlakis, ABL-Basic Research attachment of the capsid to the cell wall and does not
Program, Frederick), suggesting additional possible bind to the 12 pentameric capsomeres at the vertices,
mechanisms for chemotaxis inhibition. G. Pavlakis pro- and the other one (#9) prevents attachment. It appears
posed an interesting mechanism of the switch from that 5B6 was bivalently bound to the capsid; while #9,
M-tropic to T-tropic HIV-1 isolates during progression monovalently. It is known that some MAbs affect postat-
to AIDS based on the observation that IL-4 down-modu- tachment stages of entry only in their bivalent form but
lates CCR5 and that IL-4 is increased in HIV-infected whether thebivalency of binding is critical for prevention
individuals. of entry by 5B6 in this case is unknown.
H. Golding (FDA, Bethesda) discussed a study de- The determination of the X-ray crystal structures of
signed to determine whether restricted transmission of antiviral drugs complexed with human rhinovirus (Smith
HIV-1 correlates with the expression and function of et al., 1986) initiated a number of studies for develop-
HIV-1 coreceptors on Langerhans cells (LC) in mucosal ment of antiviral compounds, although virus resistance
epithelium and macrophages (MF). It was found that is a major concern (M. Rossmann). In some cases, bind-
freshly isolated epidermal LC expressed CCR5 but not ing of antiviral drugs can induce significant conforma-
CXCR4 at the plasma membrane surface; however, LC tional changes in the virus structure. In other cases, it
contained intracellular preformed CXCR4 that was has been found that minor structural changes accom-
transported to the surface during the tissue culturing. pany the binding of antiviral compounds. The minor
MF expressed high levels of both coreceptors but only structural changes caused by drug binding suggest a
CCR5 was functional in a fusion assay. These data pro- model of drug action in which it is the conformational
vide several possible explanations for the selective changes prevented by the bound drug and stabilization
transmission of MF-tropic HIV isolates and for the resis- of the virus, rather than obvious conformational changes
tance to infection conferred by the CCR5 deletion mu- induced by drug binding, which exert the biological ef-
tant. An interesting observation that influenza infection fect (Grant et al., 1994). The major advances in our un-
enhances HIV-1 entry but only of T-tropic isolates may derstanding of picornavirus structure have permitted
suggest a new mechanism of the relationships between rational design of drugs that can bind near the virion
the HIV-1 disease and other infections (A. Puri, NCI- attachment site and block virus infection. Similarities
FCRDC, Frederick; R. Carroll, NMRI, Bethesda; R. Blu- in the basic design of the receptor ICAM-1 for human
menthal). The overall conclusion from these presenta- rhinovirus and CD4 may suggest new ideas for designing
tions is that while coreceptors are certainly important inhibitors of HIV-1 entry.
for HIV-1 pathogenesis, their effects are complex and Although hundreds of HIV-1 entry inhibitors have been
should be considered in the context of the multifactorial identified (reviewed in chapter 10 of Dimitrov and
nature of the HIV-1 disease determined by the delicate Broder, 1997), none of them has been successful in
balance between virus replication and host immune re- clinical trials until very recently. The most potent of the
sponse. specific HIV-1 inhibitors is the gp41 peptide DP178,
identified by C. Wild, T. Matthews, and their colleagues
(Wild et al., 1994), which is presently in clinical trials andVirus Entry as a Target in Treatment of Diseases
Entry is a very attractive target for inhibition. It is an shows high efficacy (E. Hunter). It appears that at 50
ng/ml DP178 can clamp the gp120-gp41 fusion cascadeimportant stage of the virus life cycle that determines
to a large extent the viral tropism and pathogenesis. The in a hemifusion intermediate (I. Munoz-Barroso; R. Blu-
menthal, NCI-FCRDC, Frederick). Moreover, DP178 in-participating molecules are exposed to the extracellular
medium and therefore are relatively easier to reach than teracts with the gp41 structure after CD4-induced con-
formational changes. The recent solution of the 3-Dintracellular targets. Antibodies against virus proteins
are produced in infected individuals as a part of the structure of a fragment from gp41 (Chan et al., 1997;
Weissenhorn et al., 1997) offers new possibilities fornatural immune response and therefore can serve as
a paradigm for an efficient entry inhibitor. For human structure-based design of small molecule inhibitors of
HIV-1 entry (P. Kim). Synthetic peptides from differentrhinoviruses, which are the major causative agent of the
common cold and have one of the best characterized regions in the fusion protein of Sendai virus were shown
by Y. Shai to be potent inhibitors of virus±cell fusionvirus structures, it has been discussed that antibodies
can not penetrate the narrow canyon where the receptor before or after attachment of the virus to cells. SV-473,
the heptad repeat in Sendai virus which is homolog tobinds (M. Rossmann). A recent study of the structure
of human rhinovirus 14 (HRV14) complexed with Fab DP-178 in HIV-1, was shown to be a potent inhibitor
before and after attachment (Rapaport et al., 1995),fragments (Fab17-IA) from a strongly neutralizing anti-
body found that the Fab fragment contacts regions ex- whereas SV-201 inihibited only before virus attachment
to cells.tensively overlapping those residues involved in recep-
tor recognition (Smith et al., 1996). The virus surface The discovery last year of the HIV-1 coreceptors stim-
ulated new efforts for identification of entry inhibitorscovered by the antibody, however, is much larger than
that covered by the receptor ICAM-1. Therefore, by mu- that prevent their interactions with the Env-CD4. Chemo-
kines can compete with the Env-CD4 complex and po-tating those residues that are involved in antibody rec-
ognition but not in interactions with the receptor, the tently inhibit entry (J. Sodroski). Peptides from the N
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terminus of CXCR4 can inhibit infection albeit at high tissues in vivo (N. Templeton, NCI-FCRDC, Frederick).
Cryo-EM demonstrated that the DNA-liposome com-concentrations (E. Berger). A previously described small
(9 residues) derivatized peptide (ALX) inhibits HIV-1 in- plexes have a novel morphology that may account for
the high efficiency of gene delivery in vivo and the broadfection and fusion at relatively low concentrations by
interacting with the first and second extracellular loops tissue distribution (Templeton et al., 1997). Studies are
in progress to place ligands on these complexes to spe-of CXCR4 (R. Doms). These are the same regions that
are important for the HIV-1 coreceptor activity. Although cifically target the delivery system.
this molecule does not inhibit entry mediated by CCR5,
and the virus could evolve to use other coreceptors in
Future Perspectivespresence of ALX, it is an important step as proof of
The future seems bright for studies of virus entry withthe concept that coreceptors can be a target of small
several daunting tasks ahead: (1) elucidation of the mo-molecule inhibitors of HIV-1 infection. In addition, at the
lecular details of the entry mechanisms by combinationlate stages of the HIV-1 disease, when CXCR4 usage
of structural, molecular biological, biochemical, and bio-may dominate in some patients, such inhibitors still
physical methods; (2) extensive characterization of the
could be useful in combination with other drugs.
late stages of virus entry including uncoating, which
have received relatively little attention during the last
decade; (3) identification of more receptor and corecep-Delivery Systems
tor molecules, as well as viral entry proteins, and theirUnderstanding the mechanisms of virus entry and mem-
characterization; (4) elucidation of the role of entry inbrane fusion can greatly enhance our ability to develop
virus tropism, evolution, and pathogenesis; (5) develop-delivery systems targeting specific cell types. Presently,
ment of novel inhibitors of virus entry; and (6) engi-70% of the 250 clinical trials using gene delivery systems
neering of virus-based delivery systems targeted to spe-are based on retroviral vectors. P. Cannon (University
cific cell types. In the next century, we will certainlyof Southern California, Los Angeles) described the suc-
witness a more complete understanding of the cell biol-cesses and failures to engineer the ecotropic Moloney
ogy of viral entry and, hopefully, the development ofmurine leukemia virus (MoMuLV) envelope protein to
virus entry machines with predetermined character-target specific human cells by theconstruction of chime-
istics.ric proteins containing peptide ligands or single chain
antibodies directed against cell surface proteins. Al-
though these chimeric molecules do bind their recep- Acknowledgments
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